ID: ALA5208925

Max Phase: Preclinical

Molecular Formula: C14H17NO

Molecular Weight: 215.30

Representations

Canonical SMILES:  O=C(N1CCCC1)C1(c2ccccc2)CC1

Standard InChI:  InChI=1S/C14H17NO/c16-13(15-10-4-5-11-15)14(8-9-14)12-6-2-1-3-7-12/h1-3,6-7H,4-5,8-11H2

Standard InChI Key:  ROYIWLBHKRZKKJ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 215.30

Molecular Weight (Monoisotopic): 215.1310

AlogP: 2.34

#Rotatable Bonds: 2

Polar Surface Area: 20.31

Molecular Species: NEUTRAL

HBA: 1

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 2

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 2.29

CX LogD: 2.29

Aromatic Rings: 1

Heavy Atoms: 16

QED Weighted: 0.74

Np Likeness Score: -0.95

References

1. Zhang C, Xu M, He C, Zhuo J, Burns DM, Qian DQ, Lin Q, Li YL, Chen L, Shi E, Agrios C, Weng L, Sharief V, Jalluri R, Li Y, Scherle P, Diamond S, Hunter D, Covington M, Marando C, Wynn R, Katiyar K, Contel N, Vaddi K, Yeleswaram S, Hollis G, Huber R, Friedman S, Metcalf B, Yao W..  (2022)  Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach.,  69  [PMID:35537608] [10.1016/j.bmcl.2022.128782]

Source

Source(1):

• Scientific Literature